vimarsana.com

Page 4 - மேம்படுத்துகிறது உலகளாவிய ஔட்கம்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

KidneyIntelX found effective in patients with early stage disease

KidneyIntelX found effective in patients with early stage disease ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS You ve successfully added to your alerts. You will receive an email when new content is published. Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Investigators found the diabetic kidney disease progression test KidneyIntelX, by RenalytixAI plc, successfully risk stratified a large cohort of patients for disease progression, according to a press release.

New guidelines aims to help reduce blood pressure for chronic kidney disease patients

New guidelines aim to help reduce blood pressure for chronic kidney disease patients A recommendation for more intensive blood pressure management from an influential global nonprofit that publishes clinical practice guidelines in kidney disease could, if followed, benefit nearly 25 million Americans, according to an analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health. The new recommendation from Kidney Disease: Improving Global Outcomes, a global nonprofit that develops evidence-based clinical practice guidelines in kidney disease, is aimed at doctors to help them to reduce blood pressure for chronic kidney disease patients whose systolic blood pressure levels are over 120 mmHg. Blood pressure can be reduced using antihypertensive medications and lifestyle modifications. The analysis indicates that 69.5 percent of chronic kidney disease patients in the United States a total of 24.5 million people would meet that criterion.

Health guidelines could benefit 25 million Americans with chronic kidney disease

Health guidelines could benefit 25 million Americans with chronic kidney disease New guidelines call for bringing blood pressure levels down to 120 mmHg systolic in chronic kidney disease patients Credit: Getty Images Feb 24, 2021 A recommendation for more intensive blood pressure management from an influential global nonprofit that publishes clinical practice guidelines in kidney disease could, if followed, benefit nearly 25 million Americans, according to an analysis led by researchers at the Johns Hopkins Bloomberg School of Public Health. The new recommendation published by Kidney Disease: Improving Global Outcomes, a global nonprofit that develops evidence-based clinical practice guidelines in kidney disease is aimed at doctors to help them to reduce blood pressure for chronic kidney disease patients whose systolic blood pressure levels are over 120 mmHg. Blood pressure can be reduced using antihypertensive medications and lifestyle modifications. The analysis indicates

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.